Welcome to our dedicated page for Fresenius Med Cr SEC filings (Ticker: FMCQF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for FRESENIUS MED CARE AG ORD (FMCQF) on Stock Titan provides access to regulatory documents that Fresenius Medical Care AG submits as a foreign private issuer. The company files annual reports under Form 20-F and furnishes interim information on Form 6-K under the Securities Exchange Act of 1934.
Form 6-K filings for Fresenius Medical Care AG frequently include exhibits such as press releases announcing quarterly results and detailed financial overviews for specified periods. One example described in the filings is a press release for third quarter results accompanied by a complete overview of performance for that quarter and the first nine months of the year. Other 6-K reports furnish information disclosed under the EU Market Abuse Regulation, as well as press releases dated on particular days.
In its filings, the company notes that it prepares consolidated financial results in accordance with IFRS and supplements these with non-GAAP financial measures. These measures include EBITDA, free cash flow, a net leverage ratio and results presented in constant currency or adjusted for special items. The filings explain that reconciliations from these non-GAAP figures to the most comparable IFRS measures are included in the attached financial statements or tables.
On Stock Titan, users can review these filings as they are made available from EDGAR and use AI-powered summaries to interpret the technical language. The platform highlights key elements from Form 6-K and Form 20-F reports, helping readers understand segment references such as Health Care Services, Health Care Products, Value Based Care, Care Delivery and Care Enablement, as well as disclosures about non-GAAP metrics and their reconciliations.
Investors interested in FMCQF can use this page to locate the latest 6-K submissions, annual 20-F reports and related exhibits, and to see how Fresenius Medical Care AG presents its financial performance and regulatory disclosures over time.
Fresenius Medical Care AG furnished a Form 6-K announcing its third quarter results for the period ended September 30, 2025. The submission includes a press release (Exhibit 99.1) and accompanying financial figures (Exhibit 99.2).
The company highlights non-GAAP measures alongside IFRS results, including EBITDA, free cash flow, net leverage ratio (net debt to adjusted EBITDA), constant-currency metrics, and results adjusted for special items, with reconciliations provided in the exhibits. The exhibits are furnished, not filed.